Business Context and Reporting Period
This Form 8-K Current Report was filed by Sintx Technologies, Inc. on October 11, 2023. The company, incorporated in Delaware and trading on the NASDAQ Capital Market under the symbol "SINT," reported a material event occurring on the same date.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a specific corporate event rather than periodic financial performance.
Material Changes
The primary material event reported is the award of a grant from the National Institutes of Health (NIH) to the Company, announced via a press release on October 11, 2023.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the NIH grant. The filing does not contain updated financial guidance, specific risk factors, or details on contingencies beyond the grant award itself. Further details regarding the grant are referenced in the attached press release (Exhibit 99.1).
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for the specific dollar amount and terms of the NIH grant.
- Verify the impact of the grant on the company's cash runway and research and development timeline.
- Confirm the status of the company's clinical trials and product pipeline as of the filing date.
- Check subsequent filings for any conditions attached to the NIH funding.